Announcement under Regulation 30 (LODR)-Newspaper Publication
We herewith enclose the copy of Newspaper publication published in connection wi...Read More
03/09/2024
Notice Of 29Th Annual General Meeting Of The Company For The F.Y 2023-2024
We herewith enclose the Notice of 29th Annual General Meeting of the Company to ...Read More
02/09/2024
Reg. 34 (1) Annual Report.
We herewith enclose the Annual Report of the Company for the F.Y 2023-2024.
02/09/2024
Book Closure For 29Th Annual General Meeting (AGM)
Intimation for Book Closure for the purpose of 29th Annual General Meeting of th...Read More
30/08/2024
Shareholder Meeting - 29Th AGM On September 25 2024
We hereby inform that the 29th Annual General Meeting (AGM) will be held on Wedn...Read More
30/08/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby enclose the Newspaper Publication for the Unaudited Financial Results ...Read More
16/08/2024
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 for Sale / Dispos...Read More
13/08/2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13/08/2024
The Board of Directors in the meeting held on 13/08/2024 has inter-alia approved...Read More
13/08/2024
Unaudited Financial Results For The Quarter Ended 30.06.2024
Unaudited Financial Results for the Quarter ended 30.06.2024
13/08/2024
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The First Quarter Ended June 30 2024.
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Dire...Read More
06/08/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for quarter end...Read More
11/07/2024
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations For Temporary Disruption Of Operations.
Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 for Temporary Dis...Read More
29/06/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby enclose the Newspaper Publication for the Audited Financial Results fo...Read More
31/05/2024
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2024
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Dire...Read More
22/05/2024
Announcement Regarding Inauguration Of New Quality Control Laboratory Of Company
We are delighted to announce the inauguration of new State-of-the-Art Quality Co...Read More
26/04/2024
Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations 2015 For The Period Ended 31St March 2024
We are herewith submitting the Compliance Certificate under Regulation 7(3) of S...Read More
24/04/2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
We hereby inform that Mr. Vishnu Vasudeva Kuppa has resigned from the position o...Read More
23/04/2024
Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March 2024
We are herewith enclosing the Compliance Certificate issued under Regulation 40(...Read More
22/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
We are herewith enclosing Certificate under Regulation 74(5) of SEBI (DP) Regula...Read More
15/04/2024
Closure of Trading Window
The Trading Window for the designated persons connected persons shall remain clo...Read More
